CymaBay Therapeutics, Inc.

Susquehanna Portfolio Strategies, LLC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

58,123

Value ($000)

1,373

Weight

0.0%

2023 Q4 - 2023 Q4 (1 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	1,373	0.0%	58,123	12/31/2023